|Degree:||Master of Science (MSc)|
|Application deadline:||05 Jan 2022 passed|
|University website:||Pharmaceutical Research, Development and Safety|
|Annual tuition (EEA)||0 EUR|
|Annual tuition (non-EEA)||18,000 EUR|
The Master’s Programme in Pharmaceutical Research, Development and Safety offers the opportunity to obtain a comprehensive overview of the life cycle of drugs and their use. The study program combines compulsory and optional courses with study tracks that focus on three possible subdisciplines: 1) drug discovery and pharmacology, 2) drug development and 3) medication safety and effectiveness. The programme combines research-oriented studies and high-quality pedagogical methods and integrates the perspective of Green and Sustainable Pharmacy into the curriculum, essential for managing the global sustainability challenge.
Upon graduating, you earn a degree in pharmaceutical sciences and gain expertise relevant to a wide range of careers in R&D and healthcare regulatory and management tasks in academia, pharmaceutical industry or the public sector (e.g. regulatory agencies). The programme is hosted by the Faculty of Pharmacy, University of Helsinki, an internationally recognised drug research institute.
The ageing population and the need for rapidly evolving medication solutions are factors that highlight the growing role and need of experts in pharmaceuticals, their use and regulatory processes in society.
In the Master’s Programme in Pharmaceutical Research, Development and Safety, you will:
Please note that the degree earned in this programme does not qualify for legalized healthcare professional status in the EU area.